Chittaranjan Das

Dr. Chittaranjan Das

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MSMichael J. Sheedlo
Michael J. Sheedlo
JQJiazhang Qiu
Jiazhang Qiu
YTYunhao Tan
Yunhao Tan
LPLake N. Paul
Lake N. Paul
ZLZhaoqing Luo
Zhaoqing Luo
CDChittaranjan Das
Chittaranjan Das
Significance: Ubiquitination and deubiquitination have emerged in recent years as novel targets for the design of therapeutic agents. To our knowledge, the structure of the deubiquitinase (DUB) domain of SdeA represents the first prokaryotic DUB determined and will thus potentially serve as a model for other bacterial deubiquitinating enzymes for use in structure-guided drug design. Legionella pneumophila ubiquitin E3 ligases play important roles in the biogenesis of the phagosome permissive for bacterial replication. The discovery of effectors with DUB activity highlights the importance of modulation of host processes in a regulated and balanced manner.

3 May 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
DBDavid A. Boudreaux
David A. Boudreaux
TMTushar K. Maiti
Tushar K. Maiti
CDChristopher W. Davies
Christopher W. Davies
CDChittaranjan Das
Chittaranjan Das
Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) is a Parkinson disease-associated, putative cysteine protease found abundantly and selectively expressed in neurons. The crystal structure of apo UCHL1 showed that the active-site residues are not aligned in a canonical form, with the nucleophilic cysteine being 7.7 Å from the general base histidine, an arrangement consistent with an inactive form of the enzyme. Here we report the crystal structures of the wild type and two Parkinson disease-associated variants of the enzyme, S18Y and I93M, bound to a ubiquitin-based suicide substrate, ubiquitin vinyl methyl ester. These structures reveal that ubiquitin vinyl methyl ester binds primarily at two sites on the enzyme, with its carboxy terminus at the active site and with its amino-terminal β-hairpin at the distal site—a surface-exposed hydrophobic crevice 17 Å away from the active site. Binding at the distal site initiates a cascade of side-chain movements in the enzyme that starts at a highly conserved, surface-exposed phenylalanine and is relayed to the active site resulting in the reorientation and proximal placement of the general base within 4 Å of the catalytic cysteine, an arrangement found in productive cysteine proteases. Mutation of the distal-site, surface-exposed phenylalanine to alanine reduces ubiquitin binding and severely impairs the catalytic activity of the enzyme. These results suggest that the activity of UCHL1 may be regulated by its own substrate.

1 May 2014 in Biochemistry
Verified
Journal Article
Open access
RSRashmi K. Shrestha
Rashmi K. Shrestha
JRJudith A. Ronau
Judith A. Ronau
CDChristopher W. Davies
Christopher W. Davies
RGRobert G. Guenette
Robert G. Guenette
ESEric R. Strieter
Eric R. Strieter
CDChittaranjan Das
Chittaranjan Das
AMSH, a conserved zinc metallo deubiquitinase, controls downregulation and degradation of cell-surface receptors mediated by the endosomal sorting complexes required for transport (ESCRT) machinery. It displays high specificity toward the Lys63-linked polyubiquitin chain, which is used as a signal for ESCRT-mediated endosomal–lysosomal sorting of receptors. Herein, we report the crystal structures of the catalytic domain of AMSH orthologue Sst2 from fission yeast, its ubiquitin (product)-bound form, and its Lys63-linked diubiquitin (substrate)-bound form at 1.45, 1.7, and 2.3 Å, respectively. The structures reveal that the P-side product fragment maintains nearly all the contacts with the enzyme as seen with the P portion (distal ubiquitin) of the Lys63-linked diubiquitin substrate, with additional coordination of the Gly76 carboxylate group of the product with the active-site Zn2+. One of the product-bound structures described herein is the result of an attempt to cocrystallize the diubiquitin substrate bound to an active site mutant presumed to render the enzyme inactive, instead yielding a cocrystal structure of the enzyme bound to the P-side ubiquitin fragment of the substrate (distal ubiquitin). This fragment was generated in situ from the residual activity of the mutant enzyme. In this structure, the catalytic water is seen placed between the active-site Zn2+ and the carboxylate group of Gly76 of ubiquitin, providing what appears to be a snapshot of the active site when the product is about to depart. Comparison of this structure with that of the substrate-bound form suggests the importance of dynamics of a flexible flap near the active site in catalysis. The crystal structure of the Thr319Ile mutant of the catalytic domain of Sst2 provides insight into structural basis of microcephaly capillary malformation syndrome. Isothermal titration calorimetry yields a dissociation constant (KD) of 10.2 ± 0.6 μM for the binding of ubiquitin to the enzyme, a value comparable to the KM of the enzyme catalyzing hydrolysis of the Lys63-linked diubiquitin substrate (∼20 μM). These results, together with the previously reported observation that the intracellular concentration of free ubiquitin (∼20 μM) exceeds that of Lys63-linked polyubiquitin chains, imply that the free, cytosolic form of the enzyme remains inhibited by being tightly bound to free ubiquitin. We propose that when AMSH associates with endosomes, inhibition would be relieved because of ubiquitin binding domains present on its endosomal binding partners that would shift the balance toward better recognition of polyubiquitin chains via the avidity effect.

1 October 2011 in Journal of Molecular Biology
Verified
Journal Article
Closed access
CDChristopher W. Davies
Christopher W. Davies
LPLake N. Paul
Lake N. Paul
MKMyung-Il Kim
Myung-Il Kim
CDChittaranjan Das
Chittaranjan Das

13 October 2011 in The FEBS Journal
Verified
Journal Article
Open access
PDF file
TMTushar K. Maiti
Tushar K. Maiti
MPMichelle Permaul
Michelle Permaul
DBDavid A. Boudreaux
David A. Boudreaux
CMChristina Mahanic
Christina Mahanic
SMSarah Mauney
Sarah Mauney
CDChittaranjan Das
Chittaranjan Das
Ubiquitin carboxy‐terminal hydrolase L5 (UCHL5) is a proteasome‐associated deubiquitinating enzyme, which, along with RPN11 and USP14, is known to carry out deubiquitination on proteasome. As a member of the ubiquitin carboxy‐terminal hydrolase (UCH) family, UCHL5 is unusual because, unlike UCHL1 and UCHL3, it can process polyubiquitin chain. However, it does so only when it is bound to the proteasome; in its free form, it is capable of releasing only relatively small leaving groups from the C‐terminus of ubiquitin. Such a behavior might suggest at least two catalytically distinct forms of the enzyme, an apo form incapable of chain processing activity, and a proteasome‐induced activated form capable of cleaving polyubiquitin chain. Through the crystal structure analysis of two truncated constructs representing the catalytic domain (UCH domain) of this enzyme, we were able to visualize a state of this enzyme that we interpret as its inactive form, because the catalytic cysteine appears to be in an unproductive orientation. While this work was in progress, the structure of a different construct representing the UCH domain was reported; however, in that work the structure reported was that of an inactive mutant [catalytic Cys to Ala; Nishio K et al. (2009) Biochem Biophys Res Commun390, 855–860], which precluded the observation that we are reporting here. Additionally, our structures reveal conformationally dynamic parts of the enzyme that may play a role in the structural transition to the more active form.DatabaseProtein Data Bank codes: Coordinates and structure factors have been deposited in the PDB under the entries 3RII (UCHL5N228C88S) and 3RIS (UCHL5N240).

1 January 2017 in Journal of Synchrotron Radiation
Verified
Journal Article
Open access
PDF file
NSNicole M. Scarborough
Nicole M. Scarborough
GGG. M. Dilshan P. Godaliyadda
G. M. Dilshan P. Godaliyadda
DYDong Hye Ye
Dong Hye Ye
DKDavid J. Kissick
David J. Kissick
SZShijie Zhang
Shijie Zhang
GSGarth J. Simpson
Garth J. Simpson
A sparse supervised learning approach for dynamic sampling (SLADS) is described for dose reduction in diffraction-based protein crystal positioning. Crystal centering is typically a prerequisite for macromolecular diffraction at synchrotron facilities, with X-ray diffraction mapping growing in popularity as a mechanism for localization. In X-ray raster scanning, diffraction is used to identify the crystal positions based on the detection of Bragg-like peaks in the scattering patterns; however, this additional X-ray exposure may result in detectable damage to the crystal prior to data collection. Dynamic sampling, in which preceding measurements inform the next most information-rich location to probe for image reconstruction, significantly reduced the X-ray dose experienced by protein crystals during positioning by diffraction raster scanning. The SLADS algorithm implemented herein is designed for single-pixel measurements and can select a new location to measure. In each step of SLADS, the algorithm selects the pixel, which, when measured, maximizes the expected reduction in distortion given previous measurements. Ground-truth diffraction data were obtained for a 5 µm-diameter beam and SLADS reconstructed the image sampling 31% of the total volume and only 9% of the interior of the crystal greatly reducing the X-ray dosage on the crystal. Using in situ two-photon-excited fluorescence microscopy measurements as a surrogate for diffraction imaging with a 1 µm-diameter beam, the SLADS algorithm enabled image reconstruction from a 7% sampling of the total volume and 12% sampling of the interior of the crystal. When implemented into the beamline at Argonne National Laboratory, without ground-truth images, an acceptable reconstruction was obtained with 3% of the image sampled and approximately 5% of the crystal. The incorporation of SLADS into X-ray diffraction acquisitions has the potential to significantly minimize the impact of X-ray exposure on the crystal by limiting the dose and area exposed for image reconstruction and crystal positioning using data collection hardware present in most macromolecular crystallography end-stations.